187 related articles for article (PubMed ID: 30884206)
1. Candidate genes involved in metastasis of colon cancer identified by integrated analysis.
Zhou Y; Zang Y; Yang Y; Xiang J; Chen Z
Cancer Med; 2019 May; 8(5):2338-2347. PubMed ID: 30884206
[TBL] [Abstract][Full Text] [Related]
2. Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data.
Liang L; Zeng JH; Qin XG; Chen JQ; Luo DZ; Chen G
Cell Physiol Biochem; 2018; 48(2):475-490. PubMed ID: 30016783
[TBL] [Abstract][Full Text] [Related]
3. Integrated bioinformatics analysis of key genes involved in progress of colon cancer.
Yang H; Wu J; Zhang J; Yang Z; Jin W; Li Y; Jin L; Yin L; Liu H; Wang Z
Mol Genet Genomic Med; 2019 Apr; 7(4):e00588. PubMed ID: 30746900
[TBL] [Abstract][Full Text] [Related]
4. A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I-III colon cancer.
Zhou R; Zeng D; Zhang J; Sun H; Wu J; Li N; Liang L; Shi M; Bin J; Liao Y; Huang N; Liao W
EBioMedicine; 2019 Apr; 42():420-430. PubMed ID: 30917936
[TBL] [Abstract][Full Text] [Related]
5. Microarray‑based analysis of COL11A1 and TWIST1 as important differentially‑expressed pathogenic genes between left and right‑sided colon cancer.
Su C; Zhao J; Hong X; Yang S; Jiang Y; Hou J
Mol Med Rep; 2019 Nov; 20(5):4202-4214. PubMed ID: 31545476
[TBL] [Abstract][Full Text] [Related]
6. An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
Wang XJ; Zeng B; Lin S; Chen M; Chi P
Ann Clin Lab Sci; 2019 Nov; 49(6):730-739. PubMed ID: 31882423
[TBL] [Abstract][Full Text] [Related]
7. Identification and clinical validation of metastasis-associated biomarkers based on large-scale samples in colon-adenocarcinoma.
Gu L; Liu Y; Jiang C; Sun L; Zhou H
Pharmacol Res; 2020 Oct; 160():105087. PubMed ID: 32683036
[TBL] [Abstract][Full Text] [Related]
8. A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM.
Xu G; Zhang M; Zhu H; Xu J
Gene; 2017 Mar; 604():33-40. PubMed ID: 27998790
[TBL] [Abstract][Full Text] [Related]
9. Gene expression and methylation profiles identified CXCL3 and CXCL8 as key genes for diagnosis and prognosis of colon adenocarcinoma.
Zhao QQ; Jiang C; Gao Q; Zhang YY; Wang G; Chen XP; Wu SB; Tang J
J Cell Physiol; 2020 May; 235(5):4902-4912. PubMed ID: 31709538
[TBL] [Abstract][Full Text] [Related]
10. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
11. A methylation-driven gene panel predicts survival in patients with colon cancer.
Peng Y; Zhao J; Yin F; Sharen G; Wu Q; Chen Q; Sun X; Yang J; Wang H; Zhang D
FEBS Open Bio; 2021 Sep; 11(9):2490-2506. PubMed ID: 34184409
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and predictive value of an autophagy-related signature for early relapse in stages I-III colon cancer.
Mo S; Dai W; Xiang W; Li Y; Feng Y; Zhang L; Li Q; Cai G
Carcinogenesis; 2019 Jul; 40(7):861-870. PubMed ID: 30933267
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of location-specific hub genes related to the pathogenesis of colon cancer.
Shi C; Ding K; Li KZ; Long L; Li JL; Hu BL
Med Oncol; 2020 Aug; 37(9):77. PubMed ID: 32743717
[TBL] [Abstract][Full Text] [Related]
14. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
[TBL] [Abstract][Full Text] [Related]
15. LOXL2 Is Highly Expressed in Cancer-Associated Fibroblasts and Associates to Poor Colon Cancer Survival.
Torres S; Garcia-Palmero I; Herrera M; Bartolomé RA; Peña C; Fernandez-Aceñero MJ; Padilla G; Peláez-García A; Lopez-Lucendo M; Rodriguez-Merlo R; García de Herreros A; Bonilla F; Casal JI
Clin Cancer Res; 2015 Nov; 21(21):4892-902. PubMed ID: 26206869
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
17. Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
Ahluwalia P; Mondal AK; Bloomer C; Fulzele S; Jones K; Ananth S; Gahlay GK; Heneidi S; Rojiani AM; Kota V; Kolhe R
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387239
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome profiling reveals an integrated mRNA-lncRNA signature with predictive value of early relapse in colon cancer.
Dai W; Feng Y; Mo S; Xiang W; Li Q; Wang R; Xu Y; Cai G
Carcinogenesis; 2018 Oct; 39(10):1235-1244. PubMed ID: 29982331
[TBL] [Abstract][Full Text] [Related]
19. Construction of ceRNA networks reveals differences between distal and proximal colon cancers.
Qian W; Feng Y; Li J; Peng W; Gu Q; Zhang Z; Ji D; Wang Q; Zhang D; Sun Y
Oncol Rep; 2019 May; 41(5):3027-3040. PubMed ID: 30896838
[TBL] [Abstract][Full Text] [Related]
20. Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis.
Xiong J; Xiong K; Bing Z
Cancer Biomark; 2018 Feb; 21(3):535-546. PubMed ID: 29226853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]